ECS modulator (research)
UnscheduledURB754
6-methyl-2-(4-methylanilino)-3,1-benzoxazin-4-one
Aliases.URB 754 · URB-754
A purported MAGL inhibitor, in fact inactive: the activity came from a mercury impurity in the commercial lot.
Updated on
Level of detail
Harm-reduction warning
No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.
Identifiers
- Formula
- C₁₆H₁₄N₂O₂
- Molar mass
- 266.11 g·mol⁻¹
- CAS
- 86672-58-4
- PubChem CID
- 848487
- Origin
- A wholly synthetic compound with no natural occurrence. It has never had any use other than in the laboratory, and the activity that had earned it its interest did not belong to it.
- InChIKey
- GFWNGVKCDGYFKG-UHFFFAOYSA-N
In plain terms
URB754 was presented as a blocker of a cannabinoid enzyme, then unmasked: the effect came from a mercury impurity present in the bottle that was sold. The molecule itself is inactive. It is a textbook case of a reagent error.
Receptors and activity
- MAGLAucune inhibition retrouvée ; l'activité initialement rapportée revenait à une impureté organomercurielle (Saario 2006 ; Tarzia 2007)Modulator
- FAAHActivité cérébrale résistante au composé (Saario et coll. 2006)Modulator
- Agonist
- Partial agonist
- Antagonist
- Modulator
- Inverse agonist
Hover over a row for the precise value (Ki, EC50…)
Subjective signature
Hover over an axis to read its definition.
- Calm3
- Clarity3
- Sleep3
- Appetite3
- High3
Editorial estimate, not clinical.
Pharmacology
URB754 is interesting for what it is not. Published in 2005 in Nature Neuroscience as an inhibitor of monoacylglycerol lipase, arising from the screening of a commercial chemical library, it answered a real need in a field that then lacked tools for manipulating 2-arachidonoylglycerol concentrations. The correction came in two stages. In 2006 Saario and colleagues, at the University of Kuopio, report in Chemistry and Biology that they find no activity: no inhibition of 2-arachidonoylglycerol hydrolysis in rat brain, no inhibition of fatty acid amide hydrolase, no ability to reveal 2-arachidonoylglycerol signalling on sections, where a reference inhibitor succeeds without difficulty. Their conclusion is blunt: the compound cannot serve as a lead structure for developing inhibitors of that enzyme. In 2007 the group that had made the original publication itself identified the cause of the error. Analysis of the commercial lot by chromatography coupled to mass spectrometry and by nuclear magnetic resonance revealed an organomercurial impurity, bis(methylthio)mercurane, whose median inhibitory concentration at the enzyme is 11.9 nanomolar: it was this, and not the benzoxazinone, that carried all the observed activity. The 2005 work was the subject of an erratum published in Nature Neuroscience in 2007. The episode has a general and lasting reach: the apparent potency of a compound arising from a screen on commercial material is worth only as much as the purity of the lot, and attributing an activity to a structure requires that traces have been ruled out.
Key sources.
- Saario et coll. 2006 : l'URB754 n'a aucun effet sur l'hydrolyse ni sur la capacité de signalisation du 2-AG dans le cerveau de ratPMID 16931330
- Tarzia et coll. 2007 : identification d'une impureté bioactive dans un échantillon commercial d'URB754PMID 17970304
- Makara et coll. 2005 : attribution initiale de l'activité, corrigée par un erratum publié en 2007PMID 16116451
Origin (research tool)
An entirely chemical route, described here by class only. The molecule is a benzoxazinone: a 3,1-benzoxazin-4-one core bears a methyl on the aromatic ring and an anilino function substituted by a methylphenyl. That skeleton is classically associated with the inhibition of serine hydrolases, which initially made the activity attributed to it plausible.
Legal framework
France
A substance not listed among narcotics or among psychotropics. Its benzoxazinone skeleton falls under none of the families added to Annex IV of the arrêté of 22 February 1990 by the arrêté of 31 March 2017. The compound has never had human use.
European Union
Neither controlled nor authorised. No listing under the international conventions of 1961 and 1971. The compound holds the status of a laboratory chemical.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Structural classification
- Class
- ECS modulator (research)
- Origin
- A wholly synthetic compound with no natural occurrence. It has never had any use other than in the laboratory, and the activity that had earned it its interest did not belong to it.
- Status
- Unscheduled
References
- 1.Saario et coll. 2006 : l'URB754 n'a aucun effet sur l'hydrolyse ni sur la capacité de signalisation du 2-AG dans le cerveau de ratPMID 16931330
- 2.Tarzia et coll. 2007 : identification d'une impureté bioactive dans un échantillon commercial d'URB754PMID 17970304
- 3.Makara et coll. 2005 : attribution initiale de l'activité, corrigée par un erratum publié en 2007PMID 16116451
Structured data
- InChIKey
- GFWNGVKCDGYFKG-UHFFFAOYSA-N
- SMILES
- CC1=CC=C(C=C1)NC2=NC3=C(C=C(C=C3)C)C(=O)O2
- Formula
- C16H14N2O2
- Molar mass
- 266.11 g·mol⁻¹
- CAS
- 86672-58-4
- PubChem CID
- 848487
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.